Back to Results
First PageMeta Content
Merial / Sanofi Pasteur / Saputo Stadium / Epinephrine autoinjector / Pharmaceutical industry / Association football / Montreal / Public Readiness and Emergency Preparedness Act / Montreal Impact / Medicine / Sanofi


New Partnership between “Talking” Epinephrine Auto-Injector, Allerject™, and the Montreal Impact Montreal, May 8, 2014 – Sanofi Canada is proud to announce that Allerject™, its epinephrine auto-injector, is now
Add to Reading List

Document Date: 2014-05-13 13:48:52

Open Document

File Size: 155,33 KB

Share Result on Facebook

City

Montreal / New York / Paris / /

Company

Sanofi Canada / Facebook / Genzyme / /

Continent

North America / /

Country

Canada / /

Currency

USD / /

/

Event

Company Listing Change / /

IndustryTerm

pharmaceuticals / therapeutic solutions / consumer healthcare / healthcare / over-the-counter products / diabetes solutions / /

MedicalCondition

anaphylaxis / diabetes / severe allergies / /

MedicalTreatment

first-aid / emergency treatment / /

Organization

Impact / CONCACAF Champions League / Republicans / /

Person

Patrick Vallée / Jon Fairest / Robert Stephens / /

/

Position

President and CEO / Director / Communications / global healthcare leader / /

Product

Epinephrine / /

SportsEvent

the CONCACAF Champions League / /

SportsGame

soccer / /

SportsLeague

the most prestigious soccer league / CONCACAF Champions League / /

Technology

SAN / therapeutic solutions / /

URL

www.allerject.ca / /

SocialTag